DI LORENZO, ANDREA
DI LORENZO, ANDREA
A high degree of genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity.
2025-01-01 Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V
An increased genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity
2025-01-01 Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V
Brain abscess caused by Actinomyces turicensis in a non-immunocompromised adult patient: a case report and systematic review of the literature
2024-01-01 Imeneo, A; Rindi, Lv; Di Lorenzo, A; Cavasio, Ra; Vitale, P; Spalliera, I; Dauri, M; Biasucci, Dg; Giuliano, I; D'Agostini, C; Minelli, S; Cristina Bossa, M; Altieri, A; Andreoni, M; Malagnino, V; Iannetta, M; Sarmati, L
Caratterizzazione intraepatica dell'attività di HDV sostenuta dall'integrazione di HBV al baseline e sotto trattamento.
2025-01-01 Grossi, I; D'Anna, S; Di Lorenzo, A; Piermatteo, L; Ceccherini Silberstein, F; Sarmati, L; Salpini, R; Svicher, V
Chronic HDV coinfection is characterized by a more elevated production of all three HBsAg isoforms compared to HBV mono-infection, that parallels HDV replicative and cytolytic activity.
2025-01-01 D’Anna, S; Piermatteo, L; Magnapera, A; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, L; Milella, M; Saracino, Al; Ciancio, Al; Silberstein, C; F, ; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini, R
COVID ‐19 and Liver Injury, Beyond the First Pandemic Waves: Clinical and Immune‐Virological Features
2025-07-01 Foroghi Biland, L; Di Lorenzo, A; De Maria, F; Muratore, G; Compagno, M; Campogiani, L; Coppola, L; Teti, E; Malagnino, V; Iannetta, M; Sarmati, L
COVID-19 and influenza vaccination among adults stably engaged in HIV care
2025-01-01 Alessio, G; Zaçe, D; Jones, C; Di Lorenzo, A; Imeneo, A; Malagnino, V; Teti, E; Sarmati, L; Ruggiero, A; Iannetta, M; Geretti, Am
Daptomycin-Induced Eosinophilic Pneumonia: A Case Report and Systematic Review
2024-01-01 Di Lorenzo, A; Rindi, L; Campogiani, L; Imeneo, A; Alessio, G; Pace, P; Lodi, A; Rossi, B; Crea, Ama; Vitale, P; Kontogiannis, D; Malagnino, V; Andreoni, M; Sarmati, L
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing
2023-01-01 Bellocchi, Mc; Scutari, R; Carioti, L; Iannetta, M; Marchegiani, G; Piermatteo, L; Coppola, L; Tedde, S; Duca, L; Malagnino, V; Ansaldo, L; Braccialarghe, N; D′Anna, S; Mercedes Santoro, M; DI LORENZO, A; Salpini, R; Teti, E; Svicher, V; Andreoni, M; Sarmati, L; Ceccherini-Silberstein, F
HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity.
2025-01-01 Magnapera, A; Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Gaeta, Gb; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V
HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity.
2025-01-01 Magnapera, A; Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Gaeta, Gb; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Salpini, R; Svicher, V
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage.
2023-01-01 Duca, L; Olivero, A; Piermatteo, L; D’Anna, S; Torre, G; Teti, E; DI LORENZO, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; CECCHERINI SILBERSTEIN, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Rizzetto, M; Paolo Caviglia, G; Svicher, V; Salpini, R
Histoplasmosis in patients living with HIV in Europe: review of literature
2024-01-01 Kontogiannis, D; Di Lorenzo, A; Zaçe, D; Benvenuto, D; Moccione, M; Muratore, G; Giacalone, Ml; Montagnari, G; Carnevale, L; Mulas, T; Coppola, L; Campogiani, L; Sarmati, L; Iannetta, M
Lactoferrin against SARS-CoV-2: in vitro and in silico evidences
2021-01-01 Campione, E; Lanna, C; Cosio, T; Rosa, L; Conte, Mp; Iacovelli, F; Romeo, A; Falconi, M; Del Vecchio, C; Franchin, E; Lia, Ms; Minieri, M; Chiaramonte, C; Ciotti, M; Nuccetelli, M; Terrinoni, A; Iannuzzi, I; Coppeda, L; Magrini, A; Bernardini, S; Sabatini, S; Rosapepe, F; Bartoletti, Pl; Moricca, N; Di Lorenzo, A; Andreoni, M; Sarmati, L; Miani, A; Piscitelli, P; Valenti, P; Bianchi, L
Lactoferrin as antiviral treatment in COVID-19 management: preliminary evidence
2021-01-01 Campione, E; Lanna, C; Cosio, T; Rosa, L; Pia Conte, M; Iacovelli, F; Romeo, A; Falconi, M; Del Vecchio, C; Franchin, E; Lia, Ms; Minieri, M; Chiaramonte, C; Ciotti, M; Nuccetelli, M; Terrinoni, A; Iannuzzi, I; Coppeta, L; Magrini, A; Bernardini, S; Sabatini, S; Rosapepe, F; Luigi Bartoletti, P; Moricca, N; Di Lorenzo, A; Andreoni, M; Sarmati, L; Miani, A; Piscitelli, P; Squillaci, E; Valenti, P; Bianchi, L
Malagnino Valutazione della risposta biochimica e virologica dopo 72 settimane di terapia con Bulevirtide ed analisi della cinetica virale intraepatica in una coorte di pazienti affetti da epatite delta.
2025-01-01 Di Lorenzo, A; D’Anna, S; Kontogiannis, D; Teti, E; Piermatteo, L; Grossi, I; Benedetti, L; Sabuzi, F; Iannetta, M; Geretti, Am; Svicher, V; Salpini, R; Sarmati, L; Malagnino, V
The Impact of Viral and Bacterial Co-Infections and Home Antibiotic Treatment in SARS-CoV-2 Hospitalized Patients at the Policlinico Tor Vergata Hospital, Rome, Italy
2023-01-01 Di Lorenzo, A; Campogiani, L; Iannetta, M; Iannazzo, R; Imeneo, A; Alessio, G; D’Aquila, V; Massa, B; Fato, I; Rindi, Lv; Malagnino, V; Teti, E; Andreoni, M; Sarmati, L
The intrahepatic activity of Hepatitis Delta virus is sustained by an abundant production of HBs transcripts, mainly derived from integrated HBV-DNA, and is not strictly related to the extent of HBV reservoir
2023-01-01 Salpini, R; D’Anna, S; Piermatteo, L; Teti, E; Di Lorenzo, A; Brancaccio, G; Torre, G; Malagnino, V; Iannetta, M; Ceccherini Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Geretti, A; Abate, M; Milella, M; Saracino, A; Olivero, A; Gaeta, G; Sarmati, L; Rizzetto, M; Caviglia, G; Svicher, V
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2025 | A high degree of genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity. | Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2025 | An increased genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity | Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2024 | Brain abscess caused by Actinomyces turicensis in a non-immunocompromised adult patient: a case report and systematic review of the literature | Imeneo, A; Rindi, Lv; Di Lorenzo, A; Cavasio, Ra; Vitale, P; Spalliera, I; Dauri, M; Biasucci, Dg; Giuliano, I; D'Agostini, C; Minelli, S; Cristina Bossa, M; Altieri, A; Andreoni, M; Malagnino, V; Iannetta, M; Sarmati, L | Articolo su rivista | |
| 1-gen-2025 | Caratterizzazione intraepatica dell'attività di HDV sostenuta dall'integrazione di HBV al baseline e sotto trattamento. | Grossi, I; D'Anna, S; Di Lorenzo, A; Piermatteo, L; Ceccherini Silberstein, F; Sarmati, L; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2025 | Chronic HDV coinfection is characterized by a more elevated production of all three HBsAg isoforms compared to HBV mono-infection, that parallels HDV replicative and cytolytic activity. | D’Anna, S; Piermatteo, L; Magnapera, A; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, L; Milella, M; Saracino, Al; Ciancio, Al; Silberstein, C; F, ; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-lug-2025 | COVID ‐19 and Liver Injury, Beyond the First Pandemic Waves: Clinical and Immune‐Virological Features | Foroghi Biland, L; Di Lorenzo, A; De Maria, F; Muratore, G; Compagno, M; Campogiani, L; Coppola, L; Teti, E; Malagnino, V; Iannetta, M; Sarmati, L | Articolo su rivista | |
| 1-gen-2025 | COVID-19 and influenza vaccination among adults stably engaged in HIV care | Alessio, G; Zaçe, D; Jones, C; Di Lorenzo, A; Imeneo, A; Malagnino, V; Teti, E; Sarmati, L; Ruggiero, A; Iannetta, M; Geretti, Am | Articolo su rivista | |
| 1-gen-2024 | Daptomycin-Induced Eosinophilic Pneumonia: A Case Report and Systematic Review | Di Lorenzo, A; Rindi, L; Campogiani, L; Imeneo, A; Alessio, G; Pace, P; Lodi, A; Rossi, B; Crea, Ama; Vitale, P; Kontogiannis, D; Malagnino, V; Andreoni, M; Sarmati, L | Articolo su rivista | |
| 1-gen-2023 | Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing | Bellocchi, Mc; Scutari, R; Carioti, L; Iannetta, M; Marchegiani, G; Piermatteo, L; Coppola, L; Tedde, S; Duca, L; Malagnino, V; Ansaldo, L; Braccialarghe, N; D′Anna, S; Mercedes Santoro, M; DI LORENZO, A; Salpini, R; Teti, E; Svicher, V; Andreoni, M; Sarmati, L; Ceccherini-Silberstein, F | Articolo su rivista | |
| 1-gen-2025 | HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity. | Magnapera, A; Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Gaeta, Gb; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2025 | HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity. | Magnapera, A; Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Gaeta, Gb; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2023 | Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. | Duca, L; Olivero, A; Piermatteo, L; D’Anna, S; Torre, G; Teti, E; DI LORENZO, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; CECCHERINI SILBERSTEIN, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Rizzetto, M; Paolo Caviglia, G; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2024 | Histoplasmosis in patients living with HIV in Europe: review of literature | Kontogiannis, D; Di Lorenzo, A; Zaçe, D; Benvenuto, D; Moccione, M; Muratore, G; Giacalone, Ml; Montagnari, G; Carnevale, L; Mulas, T; Coppola, L; Campogiani, L; Sarmati, L; Iannetta, M | Articolo su rivista | |
| 1-gen-2021 | Lactoferrin against SARS-CoV-2: in vitro and in silico evidences | Campione, E; Lanna, C; Cosio, T; Rosa, L; Conte, Mp; Iacovelli, F; Romeo, A; Falconi, M; Del Vecchio, C; Franchin, E; Lia, Ms; Minieri, M; Chiaramonte, C; Ciotti, M; Nuccetelli, M; Terrinoni, A; Iannuzzi, I; Coppeda, L; Magrini, A; Bernardini, S; Sabatini, S; Rosapepe, F; Bartoletti, Pl; Moricca, N; Di Lorenzo, A; Andreoni, M; Sarmati, L; Miani, A; Piscitelli, P; Valenti, P; Bianchi, L | Articolo su rivista | |
| 1-gen-2021 | Lactoferrin as antiviral treatment in COVID-19 management: preliminary evidence | Campione, E; Lanna, C; Cosio, T; Rosa, L; Pia Conte, M; Iacovelli, F; Romeo, A; Falconi, M; Del Vecchio, C; Franchin, E; Lia, Ms; Minieri, M; Chiaramonte, C; Ciotti, M; Nuccetelli, M; Terrinoni, A; Iannuzzi, I; Coppeta, L; Magrini, A; Bernardini, S; Sabatini, S; Rosapepe, F; Luigi Bartoletti, P; Moricca, N; Di Lorenzo, A; Andreoni, M; Sarmati, L; Miani, A; Piscitelli, P; Squillaci, E; Valenti, P; Bianchi, L | Articolo su rivista | |
| 1-gen-2025 | Malagnino Valutazione della risposta biochimica e virologica dopo 72 settimane di terapia con Bulevirtide ed analisi della cinetica virale intraepatica in una coorte di pazienti affetti da epatite delta. | Di Lorenzo, A; D’Anna, S; Kontogiannis, D; Teti, E; Piermatteo, L; Grossi, I; Benedetti, L; Sabuzi, F; Iannetta, M; Geretti, Am; Svicher, V; Salpini, R; Sarmati, L; Malagnino, V | Intervento a convegno | |
| 1-gen-2023 | The Impact of Viral and Bacterial Co-Infections and Home Antibiotic Treatment in SARS-CoV-2 Hospitalized Patients at the Policlinico Tor Vergata Hospital, Rome, Italy | Di Lorenzo, A; Campogiani, L; Iannetta, M; Iannazzo, R; Imeneo, A; Alessio, G; D’Aquila, V; Massa, B; Fato, I; Rindi, Lv; Malagnino, V; Teti, E; Andreoni, M; Sarmati, L | Articolo su rivista | |
| 1-gen-2023 | The intrahepatic activity of Hepatitis Delta virus is sustained by an abundant production of HBs transcripts, mainly derived from integrated HBV-DNA, and is not strictly related to the extent of HBV reservoir | Salpini, R; D’Anna, S; Piermatteo, L; Teti, E; Di Lorenzo, A; Brancaccio, G; Torre, G; Malagnino, V; Iannetta, M; Ceccherini Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Geretti, A; Abate, M; Milella, M; Saracino, A; Olivero, A; Gaeta, G; Sarmati, L; Rizzetto, M; Caviglia, G; Svicher, V | Intervento a convegno |